Cardinal Health, Inc. (NYSE: CAH) is a Fortune 14 global healthcare services and products company headquartered in Dublin, Ohio. Cardinal Health CEO Jason Hollar leads the $222.6 billion enterprise and a workforce of approximately 48,000 employees across pharmaceutical distribution, specialty solutions, and medical products. Appointed CEO in September 2022 after serving as the company’s CFO, Hollar engineered a remarkable turnaround after a $300 million earnings drop by implementing a strategy of “ruthless prioritization.” Under his leadership, Cardinal Health has delivered record financial performance, completed over $5 billion in strategic acquisitions, and raised guidance across every fiscal quarter.

(Suggested: McKesson CEO Email & Net Worth – Brian Tyler Salary)

Jason Hollar – Quick Facts

Cardinal Health Competitors

Cardinal Health operates in the highly concentrated pharmaceutical distribution and healthcare products industry. The key competitors of Cardinal Health include:

• McKesson Corporation – Largest U.S. pharmaceutical distributor (~$309B revenue)
• Cencora, Inc. (formerly AmerisourceBergen) – Major pharma distributor (~$262B revenue)
• Medline Industries – Leading medical supplies manufacturer & distributor
• Owens & Minor – Global healthcare logistics and distribution
• Henry Schein – Healthcare products and services distribution
• Becton, Dickinson and Company – Medical technology leader
• Baxter International – Medical products and therapies

Together, McKesson, Cencora, and Cardinal Health control over 90% of the U.S. pharmaceutical distribution market, forming a powerful oligopoly in healthcare logistics.

Jason Hollar Net Worth 2026 – Cardinal Health CEO Salary

As of 2026, Jason Hollar net worth is estimated at approximately $31 million or more, based on his disclosed Cardinal Health stock holdings and SEC filings. Hollar owns approximately 200,000 shares of Cardinal Health Inc. (CAH) stock, with shares trading near all-time highs around $226 per share as of March 2026.

Cardinal Health CEO Compensation Breakdown (FY2024)

Cardinal Health Net Worth 2026 – Is Cardinal Health Profitable?

Yes, Cardinal Health is a highly profitable company. Under CEO Jason Hollar, the company has delivered consistent double-digit profit growth across all five operating segments and reached record financial performance.

Cardinal Health Financial Summary (FY2025)

(Recommended: UnitedHealth Group CEO Email & Net Worth – Andrew Witty Salary)

Cardinal Health CEO Email Address | Jason Hollar Contact

Below are the official contact details and social media profiles for Cardinal Health CEO Jason Hollar:

Career & Education – Company, University, & College

Jason Hollar’s career spans over 25 years in corporate finance, operations, and executive leadership across the automotive, retail, and healthcare industries. Known for his expertise in corporate restructurings and financial turnarounds, he has served as CFO of three major corporations before being elevated to CEO at Cardinal Health.

Jason Hollar Career Timeline

Before becoming Cardinal Health CEO, Jason Hollar built an extensive career in corporate finance. He began at Delphi Automotive in the late 1990s, gaining international experience across the United States, Europe, and South America. He subsequently held senior finance roles at Navistar International, the truck and engine manufacturer.

Hollar then took on the Chief Financial Officer role at Sears Holding Corporation during its major restructuring period. He moved on to serve as CFO of Tenneco Inc., the automotive parts company, before joining Cardinal Health as CFO in March 2020.

(Related: Pfizer CEO Email & Net Worth – Albert Bourla Salary)

At Cardinal Health, Hollar quickly demonstrated his turnaround abilities. After the company experienced a $300 million earnings drop, he implemented what he calls a strategy of “simplify and prioritize” — streamlining operations, divesting non-core businesses, and investing in high-growth areas. In September 2022, the board elevated him from CFO to CEO, recognizing his transformative impact. Under his leadership, the company has completed over $5 billion in strategic acquisitions, including Advanced Diabetes Supply (ADS) and GI Alliance, expanding into specialty pharmaceuticals and at-home health solutions.

Education

Jason Hollar Wiki – Age, Family, & More

Cardinal Health CEO Jason Hollar (age 52 as of 2026) is based in the Columbus, Ohio metro area near the company’s Dublin headquarters. Hollar keeps his personal and family life private, and details about his spouse and children are not publicly disclosed. He is known for his analytical, no-nonsense management style and his belief that “people want to win” — a philosophy he credits with gaining employee buy-in during Cardinal Health’s turnaround.

Notable Achievements & Board Memberships

• Business Roundtable Member – Active participant in shaping U.S. business and healthcare policy
• DaVita Board of Directors – Independent director at the kidney care company (NYSE: DVA)
• Junior Achievement of Central Ohio – Board member, supporting youth business education
• $5B+ in Strategic M&A – Orchestrated over $5 billion in acquisitions in 18 months, including GI Alliance and ADS
• Record Financial Performance – Delivered double-digit profit growth across all five operating segments
• Fortune 500 Turnaround – Reversed a $300 million earnings decline through “ruthless prioritization”

Hollar is a rarity in the healthcare industry — a CEO who rose to the top through CFO roles at companies in crisis. He successfully served as CFO at Sears during its restructuring, at Tenneco during its transformation, and then turned Cardinal Health around from the CFO seat before being elevated to the top job. His management philosophy centers on simplification, prioritization, and winning.

About Cardinal Health

Cardinal Health, Inc. is a global, integrated healthcare services and products company headquartered in Dublin, Ohio. Founded in 1971, the company is one of the three largest pharmaceutical distributors in the United States and operates across five key segments:

Cardinal Health trades on the New York Stock Exchange under the ticker symbol CAH. The company ranks #14 on the Fortune 500 and serves approximately 90% of U.S. hospitals and over 200,000 pharmacies worldwide, with roughly 48,000 employees globally.

Frequently Asked Questions (FAQ)

Who is the current CEO of Cardinal Health?

The current CEO of Cardinal Health is Jason M. Hollar, who was appointed Chief Executive Officer in September 2022. He previously served as the company’s CFO from 2020 to 2022. Under his leadership, Cardinal Health has achieved record financial performance and completed over $5 billion in strategic acquisitions.

What is Jason Hollar’s net worth in 2026?

As of 2026, Jason Hollar’s net worth is estimated at approximately $31 million or more, based on his disclosed Cardinal Health stock holdings of approximately 200,000 shares. With CAH stock trading near all-time highs around $226 per share, his equity holdings represent the bulk of his net worth.

What is Cardinal Health CEO’s salary?

Jason Hollar’s total compensation for fiscal year 2024 was approximately $25.65 million, including a $1.43 million base salary, $3.1 million performance bonus, and $20.6 million in stock awards. Over 94% of his compensation is performance-based.

What is Cardinal Health CEO’s email address?

Cardinal Health CEO Jason Hollar’s email address is [email protected]. He can also be reached via LinkedIn. The corporate phone number is (614) 757-5000.

What did Jason Hollar do before becoming CEO?

Before becoming Cardinal Health CEO, Jason Hollar served as the company’s Chief Financial Officer from 2020 to 2022. Prior to that, he was CFO at Tenneco Inc. and CFO at Sears Holding Corporation. Earlier in his career, he held senior finance roles at Delphi Automotive and Navistar International in the United States, Europe, and South America.

Is Cardinal Health a profitable company?

Yes, Cardinal Health is very profitable. In fiscal year 2025, the company reported $222.6 billion in revenue, $2.8 billion in non-GAAP operating earnings (up 15%), and $2.5 billion in adjusted free cash flow. All five operating segments grew profit by double digits, and the company raised its FY2026 EPS guidance to $9.65–$9.85.

Article last updated:February 2026March 4, 2026